跳至主要内容
临床试验/NCT04389749
NCT04389749招募中不适用

The Role of Continuous Passive Motion in Pain Control of Patients Undergoing Operative Management of Isolated Acetabular Fractures, Supracondylar Femur Fractures, or Tibial Plateau Fracture: A Comparative Study

University of Cincinnati2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年10月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
VAS Pain Score

研究概览

简要总结

The investigators will directly compare the visual analog scale scores and narcotic pain medication requirements in the patients who have continuous passive motion (CPM) versus those who do not during the course of the hospital admission following an open reduction internal fixation surgery for acetabular fracture, supracondylar femur fracture, or a tibial plateau fracture.

详细描述

This will be a prospective comparative cohort study analyzing the practices of three surgeons, one of whom routinely uses CPM following fixation of pelvic and acetabular fractures, and two surgeons who do not.

All patients, over the age of 18 years who have undergone open reduction and internal fixation (ORIF) of isolated acetabular fractures, supracondylar femur fractures, or tibial plateau fracture will be asked to participate. Those who consent will be randomized into two groups. The experimental group will have a CPM applied in the PACU immediately post-op and it will be utilized while the patient is awake in bed for 2 hours on and 2 hours off, when not mobilizing with Physical Therapy (PT). The experimental group will also have traditional PT, including sessions 1 to 3 times a week. The control group will have typical care, including working with physical therapy 1 to 3 times a week. The investigators will directly compare the VAS scores and narcotic pain medication requirements in the patients who have CPM versus those who do not during the course of the hospital admission. VAS scores will be assessed throughout the day by RN and/or PT. Functional outcomes will be assessed at the one-year mark using the Iowa and Majeed pelvic functional outcome tools along with the SF-12. Orthopedic Resident or Nurse Clinical will check the patient for incision integrity each day and each session of using the CPM, the patient will be monitored for adverse events. Data will be collected using Epic.

The investigators will record patient demographics including age, sex, and pre-existing narcotic usage. Fracture type according to the Orthopaedic Trauma Association will be recorded. VAS scores and pain medication requirements will be recorded from the first 48 hours during the patient's stay. Pain scores and CPM use will be obtained from Epic using the flowsheet.

Functional outcomes will be assessed at the one-year mark using the Iowa and Majeed pelvic functional outcome tools along with the SF-12.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or greater
  • Isolated acetabular fractures, supracondylar femur fractures, or tibial plateau fracture
  • Have undergone operative intervention for fracture

排除标准

  • Injury to either lower extremity that affects the patient's ability to weight bear
  • Under the age of 18
  • A prisoner

研究组 & 干预措施

CPM

Experimental

The experimental group will have a CPM applied in the PACU immediately post-op and it will be utilized while the patient is awake in bed for 2 hours on and 2 hours off, when not mobilizing with Physical Therapy (PT). The experimental group will also have traditional PT, including sessions 1 to 3 times a week.

干预措施: CPM (Device)

No CPM

No Intervention

The control group will have typical care, including working with physical therapy 1 to 3 times a week.

结局指标

主要结局

VAS Pain Score

时间窗: Visual Analog Score for pain will be recorded daily after the surgery each day until the patient is discharged or up to 365 days..

Pain will be assessed by the patient on a scale of 1-10 during hospitalization. 1=no pain; 10=worst pain

次要结局

  • SF-12(This score will be completed at the one-year post-operative visit.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

H. Claude Sagi, MD

Principal Investigator

University of Cincinnati

研究点 (2)

Loading locations...

相似试验